Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evonik Industries AG    EVK   DE000EVNK013

EVONIK INDUSTRIES AG

(EVK)
  Report
Delayed Quote. Delayed Xetra - 01/15 11:35:15 am
26.95 EUR   -1.28%
01/12EVONIK : Bernstein gives a Buy rating
MD
01/12EVONIK INDUSTRIES : begins marketing of natural refrigerants
PU
01/12EVONIK : Kepler Cheuvreux drops its Sell rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Evonik Industries : Virtual Societe Generale "The Premium Review" Conference, Paris

12/01/2020 | 12:07pm EST

Key Messages Q3 Roadshow Season

Portfolio delivering resilience in challenging environment

Strategy execution well on track

  • Acquisition of Porocel

  • Announced Baby Care carveout

  • Asset optimization in Methionine

Sustainability as key driver in innovation

  • Next generation of ready-to-use PA12 powders for 3D printing - 80% reusability

  • Biosurfactants: Evonik as key pillar in Unilever's "Clean future" initiative

Portfolio has proven resilience YTD

  • Robust performance driven by growth divisions with only -1% yoy and stable pricing

  • Many businesses virtually unaffected by the crisis

"Promise and deliver" - EBITDA outlook confirmed & FCF outlook increased

  • EBITDA outlook now narrowed:

    Range of €1.8 bn to €2.0 bn

  • FCF upgraded once more:

    FCF ~€700 m and CCR >35%

Table of contents

1. Evonik at a glance

  • 2. Strategy

  • 3. Financials Q3 2020

  • 4. Appendix

LEADING BEYOND CHEMISTRY

TO IMPROVE LIFE, TODAY AND TOMORROW

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Evonik Industries AG published this content on 02 December 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 December 2020 17:06:04 UTC


© Publicnow 2020
All news about EVONIK INDUSTRIES AG
01/12EVONIK : Bernstein gives a Buy rating
MD
01/12EVONIK INDUSTRIES : begins marketing of natural refrigerants
PU
01/12EVONIK : Kepler Cheuvreux drops its Sell rating
MD
01/11EVONIK : JP Morgan reaffirms its Buy rating
MD
01/06EVONIK : Goldman Sachs keeps its Buy rating
MD
01/06EVONIK : Gets a Buy rating from DZ Bank
MD
2020FIGHT AGAINST COVID-19 : Evonik supplies key technology for gene-based dr
PU
2020EVONIK : NorldLB sticks Neutral
MD
2020EVONIK INDUSTRIES : Support for sustainable palm oil production in Sabah, East M..
PU
2020EVONIK : Goldman Sachs reaffirms its Buy rating
MD
More news
Financials
Sales 2020 12 171 M 14 697 M 14 697 M
Net income 2020 557 M 673 M 673 M
Net Debt 2020 3 577 M 4 319 M 4 319 M
P/E ratio 2020 22,8x
Yield 2020 4,27%
Capitalization 12 536 M 15 157 M 15 137 M
EV / Sales 2020 1,32x
EV / Sales 2021 1,24x
Nbr of Employees 32 822
Free-Float 41,1%
Chart EVONIK INDUSTRIES AG
Duration : Period :
Evonik Industries AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVONIK INDUSTRIES AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 27,70 €
Last Close Price 26,95 €
Spread / Highest target 48,4%
Spread / Average Target 2,78%
Spread / Lowest Target -18,4%
EPS Revisions
Managers and Directors
NameTitle
Christian Kullmann Chairman-Executive Board
Bernd Tönjes Chairman-Supervisory Board
Ute Wolf Chief Financial Officer
Andreas Fischer Chief Innovation Officer
Siegfried Luther Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
EVONIK INDUSTRIES AG1.01%15 157
SHIN-ETSU CHEMICAL CO., LTD.5.04%75 809
BASF SE3.97%74 724
DUPONT DE NEMOURS, INC.15.79%60 451
ROYAL DSM N.V.0.60%29 041
FMC CORPORATION5.91%15 577